GlassScriptPhysician profile
William A Tuffiash
NPI 1164422754
$4,316.18
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,105 · 2020: $1,211.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,307.31 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $796.43 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $722.67 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $298.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $241.52 | 2019 | |
| Genentech USA, INC. | $222.75 | 2019-2020 | |
| Csl Behring | $170.11 | 2019-2020 | |
| Mylan Specialty L.P. | $134.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $124.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $114.93 | 2019-2020 | |
| Merz North America, INC. | $76.01 | 2019 | |
| Circassia INC. | $29.23 | 2019 | |
| Genzyme Corporation | $22.69 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.83 | 2020 | |
| Kaleo, INC. | $14.31 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.52 | 2019 | |
| Pharming Healthcare, INC. | $11.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tuffiash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.